Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Neurology and Neuroscience Reports
Erschienen in: Current Neurology and Neuroscience Reports 2/2010

01.03.2010

Management of Intraventricular Hemorrhage

verfasst von: Holly E. Hinson, Daniel F. Hanley, Wendy C. Ziai

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Brain hemorrhage is the most fatal form of stroke and has the highest morbidity of any stroke subtype. Intraventricular extension of hemorrhage (IVH) is a particularly poor prognostic sign, with expected mortality between 50% and 80%. IVH is a significant and independent contributor to morbidity and mortality, yet therapy directed at ameliorating intraventricular clot has been limited. Conventional therapy centers on managing hypertension and intracranial pressure while correcting coagulopathy and avoiding complications such as rebleeding and hydrocephalus. Surgical therapy alone has not changed the natural history of the disease significantly. However, fibrinolysis in combination with extraventricular drainage shows promise as a technique to reduce intraventricular clot volume and to manage the concomitant complications of IVH.
Literatur
1.
Brott T, Thalinger K, Hertzberg V: Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 1986, 17(6):1078–1083.PubMed
2.
Broderick JP, Brott T, Tomsick T, et al.: Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993, 78(2):188–191.CrossRefPubMed
3.
Woo D, Haverbusch M, Sekar P, et al.: Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004, 35(7):1703–1708.CrossRefPubMed
4.
Daverat P, Castel JP, Dartigues JF, Orgogozo JM: Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 1991, 22(1):1–6.PubMed
5.
Mohr G, Ferguson G, Khan M, et al.: Intraventricular hemorrhage from ruptured aneurysm. Retrospective analysis of 91 cases. J Neurosurg 1983, 58(4):482–487.CrossRefPubMed
6.
Coplin WM, Vinas FC, Agris JM, et al.: A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 1998, 29(8):1573–1579.PubMed
7.
Steiner T, Diringer MN, Schneider D, et al.: Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006, 59(4):767–773; discussion 773–764.
8.
Hallevi H, Albright KC, Aronowski J, et al.: Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology 2008, 70(11):848–852.CrossRefPubMed
9.
Young WB, Lee KP, Pessin MS, et al.: Prognostic significance of ventricular blood in supratentorial hemorrhage: a volumetric study. Neurology 1990, 40(4):616–619.PubMed
10.
•• Hallevi H, Dar NS, Barreto AD, et al.: The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med 2009, 37(3):969–974, e961. Hallevi and his group describe the relationship between ICH volume and anatomic proximity to IVH.
11.
Graeb DA, Robertson WD, Lapointe JS, et al.: Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis. Radiology 1982, 143(1):91–96.PubMed
12.
Ruscalleda J, Peiro A: Prognostic factors in intraparenchymatous hematoma with ventricular hemorrhage. Neuroradiology 1986, 28(1):34–37.CrossRefPubMed
13.
Nishikawa T, Ueba T, Kajiwara M, et al.: A priority treatment of the intraventricular hemorrhage (IVH) should be performed in the patients suffering intracerebral hemorrhage with large IVH. Clin Neurol Neurosurg 2009, 111(5):450–453.CrossRefPubMed
14.
Hemphill JC 3rd, Bonovich DC, Besmertis L, et al.: The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001, 32(4):891–897.PubMed
15.
Tuhrim S, Dambrosia JM, Price TR, et al.: Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol 1991, 29(6):658–663.CrossRefPubMed
16.
Tuhrim S, Horowitz DR, Sacher M, Godbold JH: Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999, 27(3):617–621.CrossRefPubMed
17.
Mayfrank L, Hutter BO, Kohorst Y, et al.: Influence of intraventricular hemorrhage on outcome after rupture of intracranial aneurysm. Neurosurg Rev 2001, 24(4):185–191.CrossRefPubMed
18.
Ariesen MJ, Algra A, van der Worp HB, Rinkel GJ: Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 2005, 76(6):839–844.CrossRefPubMed
19.
Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365(9457):387–397.PubMed
20.
Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352(8):777–785.CrossRefPubMed
21.
• Mayer SA, Brun NC, Begtrup K, et al.: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358(20):2127–2137. The FAST trial investigated hemostatic therapy with rFVIIa for ICH, which reduced hematoma growth but did not improve survival or functional outcome. Hematoma growth has important implications for both ICH and IVH.CrossRefPubMed
22.
Pang D, Sclabassi RJ, Horton JA: Lysis of intraventricular blood clot with urokinase in a canine model: part 1. Canine intraventricular blood cast model. Neurosurgery 1986, 19(4):540–546.PubMedCrossRef
23.
Steinke W, Sacco RL, Mohr JP, et al.: Thalamic stroke. Presentation and prognosis of infarcts and hemorrhages. Arch Neurol 1992, 49(7):703–710.PubMed
24.
Whitelaw A, Mowinckel MC, Fellman V, Abildgaard U: Endogenous tissue plasminogen activator in neonatal cerebrospinal fluid. Eur J Pediatr 1996, 155(2):117–119.CrossRefPubMed
25.
Whitelaw A: Endogenous fibrinolysis in neonatal cerebrospinal fluid. Eur J Pediatr 1993, 152(11):928–930.CrossRefPubMed
26.
Naff NJ, Williams MA, Rigamonti D, et al.: Blood clot resolution in human cerebrospinal fluid: evidence of first-order kinetics. Neurosurgery 2001, 49(3):614–619; discussion 619–621.
27.
Pang D, Sclabassi RJ, Horton JA: Lysis of intraventricular blood clot with urokinase in a canine model: part 2. In vivo safety study of intraventricular urokinase. Neurosurgery 1986, 19(4):547–552.PubMed
28.
Hutter BO, Kreitschmann-Andermahr I, Gilsbach JM: Cognitive deficits in the acute stage after subarachnoid hemorrhage. Neurosurgery 1998, 43(5):1054–1065.CrossRefPubMed
29.
Gujjar AR, Deibert E, Manno EM, et al.: Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 1998, 51(2):447–451.PubMed
30.
Roppolo LP, Walters K: Airway management in neurological emergencies. Neurocrit Care 2004, 1(4):405–414.CrossRefPubMed
31.
• Broderick J, Connolly S, Feldmann E, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007, 116(16):e391–e413. These guidelines for managing ICH form the standard of care for both ICH and IVH.
32.
Ohwaki K, Yano E, Nagashima H, et al.: Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004, 35(6):1364–1367.CrossRefPubMed
33.
Kazui S, Naritomi H, Yamamoto H, et al.: Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996, 27(10):1783–1787.PubMed
34.
• Anderson CS, Huang Y, Wang JG, et al.: Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008, 7(5):391–399. The INTERACT study investigated the relationship among blood pressure, ICH, and hematoma growth. Limiting hematoma growth is an important goal in IVH as well as ICH.
35.
• Steiner T, Kaste M, Forsting M, et al.: Recommendations for the management of intracranial haemorrhage—part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006, 22(4):294–316. The European Stroke Initiative guidelines are the European standards for treating ICH and IVH.
36.
Hart RG, Boop BS, Anderson DC: Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995, 26(8):1471–1477.PubMed
37.
Goldstein JN, Thomas SH, Frontiero V, et al.: Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 2006, 37(1):151–155.CrossRefPubMed
38.
Naidech AM, Bendok BR, Garg RK, et al.: Reduced platelet activity is associated with more intraventricular hemorrhage. Neurosurgery 2009, 65(4):684–688; discussion 688.
39.
Orken DN, Kenangil G, Ozkurt H, et al.: Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist 2009, 15(6):329–331.CrossRefPubMed
40.
Passero S, Rocchi R, Rossi S, et al.: Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002, 43(10):1175–1180.CrossRefPubMed
41.
Messe SR, Sansing LH, Cucchiara BL, et al.: Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care 2009, 11(1):38–44.CrossRefPubMed
42.
Davis SM, Broderick J, Hennerici M, et al.: Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006, 66(8):1175–1181.CrossRefPubMed
43.
Diringer MN, Edwards DF, Zazulia AR: Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 1998, 29(7):1352–1357.PubMed
44.
Adams RE, Diringer MN: Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology 1998, 50(2):519–523.PubMed
45.
Ziai WC, Torbey MT, Naff NJ, et al.: Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis 2009, 27(4):403–410.CrossRefPubMed
46.
Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A: Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 2000, 247(2):117–121.CrossRefPubMed
47.
Tuhrim S, Horowitz DR, Sacher M, Godbold JH: Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med 1995, 23(5):950–954.CrossRefPubMed
48.
LeRoux PD, Haglund MM, Newell DW, et al.: Intraventricular hemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery 1992, 31(4):678–684; discussion 684–675.
49.
Saladino A, White JB, Wijdicks EF, Lanzino G: Malplacement of ventricular catheters by neurosurgeons: a single institution experience. Neurocrit Care 2009, 10(2):248–252.CrossRefPubMed
50.
Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr: Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 2002, 51(1):170–181; discussion 181–172.
51.
Huttner HB, Staykov D, Bardutzky J, et al.: Treatment of intraventricular hemorrhage and hydrocephalus [in German]. Nervenarzt 2008, 79(12):1369–1370, 1372–1364, 1376.
52.
Ahmann PA, Lazzara A, Dykes FD, et al.: Intraventricular hemorrhage in the high-risk preterm infant: incidence and outcome. Ann Neurol 1980, 7(2):118–124.CrossRefPubMed
53.
Findlay JM, Weir BK, Gordon P, et al.: Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 1989, 24(4):491–498.CrossRefPubMed
54.
Kassell NF, Torner JC, Adams HP Jr: Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 1984, 61(2):225–230.
55.
Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978, 92(4):529–534.CrossRefPubMed
56.
Yasargil MG, Yonekawa Y, Zumstein B, Stahl HJ: Hydrocephalus following spontaneous subarachnoid hemorrhage. Clinical features and treatment. J Neurosurg 1973, 39(4):474–479.
57.
Mayfrank L, Kissler J, Raoofi R, et al.: Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment. Stroke 1997, 28(1):141–148.
58.
Wagner KR, Xi G, Hua Y, et al.: Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg 1999, 90(3):491–498.CrossRefPubMed
59.
Mayfrank L, Kim Y, Kissler J, et al.: Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator. Acta Neuropathol 2000, 100(5):561–567.CrossRefPubMed
60.
Narayan RK, Narayan TM, Katz DA, et al.: Lysis of intracranial hematomas with urokinase in a rabbit model. J Neurosurg 1985, 62(4):580–586.CrossRefPubMed
61.
Findlay JM, Weir BK, Stollery DE: Lysis of intraventricular hematoma with tissue plasminogen activator. Case report. J Neurosurg 1991, 74(5):803–807.
62.
Findlay JM, Grace MG, Weir BK: Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery 1993, 32(6):941–947; discussion 947.
63.
Andrews CO, Engelhard HH: Fibrinolytic therapy in intraventricular hemorrhage. Ann Pharmacother 2001, 35(11):1435–1448.CrossRefPubMed
64.
Naff NJ, Carhuapoma JR, Williams MA, et al.: Treatment of intraventricular hemorrhage with urokinase: effects on 30-Day survival. Stroke 2000, 31(4):841–847.PubMed
65.
Naff NJ, Hanley DF, Keyl PM, et al.: Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004, 54(3):577–583; discussion 583–574.
66.
Todo T, Usui M, Takakura K: Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 1991, 74(1):81–86.CrossRefPubMed
67.
Lapointe M, Haines S: Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst Rev 2002(3):CD003692.
68.
• Morgan T, Awad I, Keyl P, et al.: Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl 2008, 105:217–220. This article presents preliminary data from the CLEAR-IVH trial.
69.
Findlay JM, Jacka MJ: Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery 2004, 55(3):532–537; discussion 537–538.
70.
Hall B, Parker D Jr, Carhuapoma JR: Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling. Neurocrit Care 2005, 3(2):153–156.CrossRefPubMed
71.
Mendelow AD, Teasdale GM, Barer D, et al.: Outcome assignment in the International Surgical Trial of Intracerebral Haemorrhage. Acta Neurochir (Wien) 2003, 145(8):679–681; discussion 681.
72.
•• Hanley DF: Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke 2009, 40(4):1533–1538. This review article from our group discusses emerging IVH management principles.CrossRefPubMed
73.
Zhang Z, Li X, Liu Y, et al.: Application of neuroendoscopy in the treatment of intraventricular hemorrhage. Cerebrovasc Dis 2007, 24(1):91–96.CrossRefPubMed
74.
Yadav YR, Mukerji G, Shenoy R, et al.: Endoscopic management of hypertensive intraventricular haemorrhage with obstructive hydrocephalus. BMC Neurol 2007, 7:1.CrossRefPubMed
75.
Lagares A, Putman CM, Ogilvy CS: Posterior fossa decompression and clot evacuation for fourth ventricle hemorrhage after aneurysmal rupture: case report. Neurosurgery 2001, 49(1):208–211.CrossRefPubMed
76.
Shimoda M, Oda S, Shibata M, et al.: Results of early surgical evacuation of packed intraventricular hemorrhage from aneurysm rupture in patients with poor-grade subarachnoid hemorrhage. J Neurosurg 1999, 91(3):408–414.CrossRefPubMed
Metadaten
Titel
Management of Intraventricular Hemorrhage
verfasst von
Holly E. Hinson
Daniel F. Hanley
Wendy C. Ziai
Publikationsdatum
01.03.2010
Verlag
Current Science Inc.
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 2/2010
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-010-0086-6

Weitere Artikel der Ausgabe 2/2010

Current Neurology and Neuroscience Reports 2/2010 Zur Ausgabe

ReviewPaper

A Diagnostic Algorithm for Metabolic Myopathies

ReviewPaper

Advances in Pediatric Neurovirology

Clinical Trial Report

A First Step in Viral Gene Therapy for Muscular Dystrophy

ReviewPaper

The Association of Migraine with Ischemic Stroke

ReviewPaper

Congenital Muscular Dystrophies: Toward Molecular Therapeutic Interventions

ReviewPaper

Botulinum Toxin Type A for Chronic Migraine

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus
Professorin Dr. Claudia Trenkwalder, Neurologin

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein
weitere anzeigen

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise